Stemazole

CAS No. 317337-07-8

Stemazole( —— )

Catalog No. M34431 CAS No. 317337-07-8

Stemazole is a novel small molecule human stem/progenitor cell proliferation activator that promotes the survival of human embryonic stem cells and maintains stemness, and promotes the survival of oligodendrocyte precursor cells in vitro.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 160 Get Quote
5MG 235 Get Quote
10MG 377 Get Quote
25MG 771 Get Quote
50MG 1224 Get Quote
100MG 1944 Get Quote
500MG 3897 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Stemazole
  • Note
    Research use only, not for human use.
  • Brief Description
    Stemazole is a novel small molecule human stem/progenitor cell proliferation activator that promotes the survival of human embryonic stem cells and maintains stemness, and promotes the survival of oligodendrocyte precursor cells in vitro.
  • Description
    Stemazole is a protective agent that promotes stem cell survival. Stemazole has the protective effect of human embryonic stem cells (hESCs). Stemazole enhances clonal expansion of single cells and decreases apoptosis. Stemazole for the study of stem cell survival in starvation culture .
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Apoptosis
  • Target
    Apoptosis
  • Recptor
    Apoptosis
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    317337-07-8
  • Formula Weight
    267.33
  • Molecular Formula
    C9H9N5OS2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    S=C1OC(C2=CC=C(NC(NN)=S)C=C2)=NN1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Sun Y, et al. Stemazole promotes survival and preserves stemness in human embryonic stem cells. FEBS J. 2018 Feb;285(3):531-541.?
molnova catalog
related products
  • CNX-774

    CNX-774 is a highly specific, irreversible, and orally active BTK inhibitor (IC50<1 nM).

  • ZDLD20

    ZDLD20 is an orally active and selective CDK4 inhibitor, a β-carboline analog with anti-HCT116 and anticancer activity that inhibits colony formation, inhibits invasion and migration, induces apoptosis, and prevents the G1 phase of the cell cycle.

  • Resolvin D1

    Resolvin D1 (RvD1) is an endogenous pro-inflammatory mediator that blocks pro-inflammatory neutrophil migration by regulating actin polymerization.